A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy

J Gen Virol. 2003 Aug;84(Pt 8):2217-2228. doi: 10.1099/vir.0.19123-0.

Abstract

Despite numerous studies on human immunodeficiency virus type 1 (HIV-1) fitness, many key conceptual and technical questions are still unsolved. For example, the proper system to determine virus fitness of HIV-1 is still unknown. In this study, an assay was developed to estimate HIV-1 fitness based on growth competition experiments and TaqMan real-time PCR. This novel technique was compared with several methods (i.e. virus growth kinetics, growth competition/heteroduplex-tracking analysis and single-cycle replication capacity assay) in order to analyse the impact of various genomic regions and overall genetic background on virus fitness. HIV-1 primary isolates and three different sets of recombinant viruses [i.e. recombinant clones carrying protease (PR), reverse transcriptase (RT) or the 3' end of Gag, PR and RT (3'Gag/PR/RT), sequences amplified by PCR from the same primary isolates)] were evaluated. Here, it is demonstrated that, in spite of intrinsic differences, both growth competition/TaqMan and single-cycle replication assays detected a significant reduction in HIV-1 fitness as a consequence of drug-resistant mutations in pol. However, this new assay, based on HIV-1 isolates, may be useful to quantify replicative fitness in viruses from patients treated simultaneously with antiretroviral drugs targeting different genomic regions of HIV-1 (e.g. pol and env).

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-HIV Agents / pharmacology*
  • Drug Resistance, Viral / genetics
  • Drug Therapy, Combination
  • Gene Products, env / genetics
  • Gene Products, pol / genetics
  • HIV Infections / complications
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • HIV-1 / classification
  • HIV-1 / drug effects
  • HIV-1 / growth & development*
  • HIV-1 / physiology*
  • Humans
  • Polymerase Chain Reaction / methods*
  • Recombination, Genetic
  • Reverse Transcriptase Inhibitors / pharmacology*
  • Taq Polymerase / metabolism*
  • Virus Replication

Substances

  • Anti-HIV Agents
  • Gene Products, env
  • Gene Products, pol
  • Reverse Transcriptase Inhibitors
  • Taq Polymerase